TFF Pharmaceuticals Provides Update on Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant Rejection [Yahoo! Finance]
TFF Pharmaceuticals Provides Update on Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant Rejection
TFF Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update [Yahoo! Finance]
TFF Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update
TFF Pharmaceuticals Announces Closing of Pricing of $4.8 Million Public Offering [Yahoo! Finance]